Rockwell Medical Inc. Common Stock (RMTI)

About RMTI

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bic…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

157

Website

www.rockwellmed.com/

Fundamentals

1-day range

$7.7$8.25

Market cap

$28.54M

P/E (trailing)

—

P/E (forward)

116.71

EPS (trailing)

$-1.08

Dividend yield

—

Beta

1.63

Avg. volume

36.1K

Forecasts

2 analyst ratings

Rockwell Medical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• RMTI

  Rockwell Medical Inc. Common Stock

  $8.22

  ▲ 6.06%
  Market cap $28.54MP/E —
  $4.89$21
• NIKI

  Niki BioSolutions Inc. Common Stock

  $6.9

  ▼ 8.49%
  Market cap $28.45MP/E —
  $7.01$12.24
• BCTX

  BriaCell Therapeutics Corp. Common Shares

  $3.73

  ▲ 0.54%
  Market cap $29.23MP/E —
  $3.68$20.4
• ABVC

  ABVC BioPharma Inc. Common Stock

  $0.8251

  ▲ 3.66%
  Market cap $27.62MP/E —
  $0.7069$3.4
• BTAI

  BioXcel Therapeutics Inc. Common Stock

  $0.1824

  ▼ 74.63%
  Market cap $26.17MP/E —
  $0.1569$4.29
• ACTU

  Actuate Therapeutics Inc. Common stock

  $1.67

  ▼ 1.18%
  Market cap $25.36MP/E —
  $0.9$9.22
• TVRD

  Tvardi Therapeutics Inc. Common Stock

  $1.8

  ▲ 0.00%
  Market cap $25.13MP/E —
  $1.5$43.65

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Rockwell Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation
  SeekingAlpha · 8/17/2026
• Rockwell Medical, Inc. (RMTI) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/13/2026
• Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate
  benzinga · 8/13/2026
• Rockwell Medical Q2 Adj. EPS $(0.04) Beats $(0.23) Estimate, Sales $17.780M Miss $17.837M Estimate
  Benzinga · 8/13/2026
• Rockwell Medical Affirms FY2026 Sales Guidance of $70.000M-$75.000M vs $72.469M Est
  Benzinga · 8/13/2026

• Nissenson Allen · July 1, 2026 · Grant

  9.6K
• Joan Lau · July 1, 2026 · Grant

  9.6K
• Radie Robert S · July 1, 2026 · Grant

  9.6K
• COOPER JOHN G · July 1, 2026 · Grant

  9.6K
• Chole Timothy · July 1, 2026 · Grant

  15.0K
• Hunter Heather · July 1, 2026 · Grant

  15.0K
• TIMMINS MEGAN C. · July 1, 2026 · Grant

  15.0K
• Neri Jesse · July 1, 2026 · Grant

  15.0K
• Strobeck Mark · July 1, 2026 · Grant

  30.0K
• Dawson Joseph H · July 1, 2026 · Grant

  9.6K
• Hunter Heather · March 14, 2026 · Tax Withholding

  2.4K @ $0.9
• TIMMINS MEGAN C. · March 14, 2026 · Tax Withholding

  3.7K @ $0.9
• Neri Jesse · March 14, 2026 · Tax Withholding

  2.4K @ $0.9
• Chole Timothy · March 14, 2026 · Tax Withholding

  2.4K @ $0.9
• Strobeck Mark · March 14, 2026 · Tax Withholding

  7.3K @ $0.9